<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35643629</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1542-0086</ISSN><JournalIssue CitedMedium="Internet"><Volume>121</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Jul</Month><Day>05</Day></PubDate></JournalIssue><Title>Biophysical journal</Title><ISOAbbreviation>Biophys J</ISOAbbreviation></Journal><ArticleTitle>The SGYS motif of TAF15 prion-like domain is&#xa0;critical to amyloid fibril formation.</ArticleTitle><Pagination><StartPage>2613</StartPage><EndPage>2623</EndPage><MedlinePgn>2613-2623</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bpj.2022.05.038</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0006-3495(22)00431-3</ELocationID><Abstract><AbstractText>Misfolding of TATA-box binding protein-associated factor 15 (TAF15) may cause neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS). Some mutations of prion-like domain (PrLD) have been detected in patients with sporadic ALS, suggesting the importance of TAF15-PrLD in ALS pathogenesis. Herein, combining experiments and molecular dynamics (MD) simulations, we investigated the influences of several TAF15-PrLD mutations on the amyloid fibril formation of TAF15-PrLD-extracted peptide segments, and identified an essential &#x3b2;-amyloid-forming segment from TAF15-PrLD. A pathogenic mutation T2 E71G resulted in significantly enhanced aggregation of the TAF15-PrLD segment T2 (Y<sup>56</sup>GQSQSGYSQSYGGYENQ<sup>73</sup>). In addition, the peptide T2 with a strong &#x3b2;-amyloid-forming tendency was able to induce the liquid to solid phase transition of TAF15-PrLD protein. Further study identified the SGYS motif as a critical segment that promoted the formation of amyloid fibrils, which maintained a stable &#x3b2;-sheet structure through intermolecular hydrogen bonds and &#x3c0;-&#x3c0; stacking interaction. This work provides a clue to elucidate the molecular pathogenic mechanism of TAF15-associated neurodegenerative diseases, and will direct drug development targeting TAF15.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Biophysical Society. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Jialin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China; State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Xiushuang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Peng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Daoping</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China; The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Chen</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Quanqiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shi-Zhong</ForeName><Initials>SZ</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. Electronic address: luosz@mail.buct.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. Electronic address: chenlong@mail.buct.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biophys J</MedlineTA><NlmUniqueID>0370626</NlmUniqueID><ISSNLinking>0006-3495</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000682">Amyloid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000072002">Prion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011328">Prions</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C102041">TAF15 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035381">TATA-Binding Protein Associated Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000682" MajorTopicYN="N">Amyloid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072002" MajorTopicYN="N">Prion Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011328" MajorTopicYN="Y">Prions</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035381" MajorTopicYN="Y">TATA-Binding Protein Associated Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>9</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35643629</ArticleId><ArticleId IdType="pmc">PMC9300678</ArticleId><ArticleId IdType="doi">10.1016/j.bpj.2022.05.038</ArticleId><ArticleId IdType="pii">S0006-3495(22)00431-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ticozzi N., Vance C., et al. Landers J. Mutational analysis reveals the FUS homolog TAF15 as a candidate gene for familial amyotrophic lateral sclerosis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2011;156:285&#x2013;290. doi: 10.1002/ajmg.b.31158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.31158</ArticleId><ArticleId IdType="pubmed">21438137</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.Q., Tan M.S., et al. Tan L. Frontotemporal lobar degeneration: mechanisms and therapeutic strategies. Mol. Neurobiol. 2016;53:6091&#x2013;6105. doi: 10.1007/s12035-015-9507-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9507-5</ArticleId><ArticleId IdType="pubmed">26537902</ArticleId></ArticleIdList></Reference><Reference><Citation>Svetoni F., Frisone P., Paronetto M.P. Role of FET proteins in neurodegenerative disorders. RNA Biol. 2016;13:1089&#x2013;1102. doi: 10.1080/15476286.2016.1211225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2016.1211225</ArticleId><ArticleId IdType="pmc">PMC5100351</ArticleId><ArticleId IdType="pubmed">27415968</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo F., Gui X., et al. Liu C. Atomic structures of FUS LC domain segments reveal bases for reversible amyloid fibril formation. Nat. Struct. Mol. Biol. 2018;25:341&#x2013;346. doi: 10.1038/s41594-018-0050-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-018-0050-8</ArticleId><ArticleId IdType="pubmed">29610493</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W., Dunlap J.R., et al. Wetzel R. Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 2002;11:2905&#x2013;2917. doi: 10.1093/hmg/11.23.2905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.23.2905</ArticleId><ArticleId IdType="pubmed">12393802</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.M., Ferrone F.A., Wetzel R. Huntington&#x2019;s disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2002;99:11884&#x2013;11889. doi: 10.1073/pnas.182276099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.182276099</ArticleId><ArticleId IdType="pmc">PMC129363</ArticleId><ArticleId IdType="pubmed">12186976</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherzinger E., Sittler A., et al. Wanker E.E. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 1999;96:4604&#x2013;4609. doi: 10.1073/pnas.96.8.4604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.8.4604</ArticleId><ArticleId IdType="pmc">PMC16379</ArticleId><ArticleId IdType="pubmed">10200309</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayed R., Head E., et al. Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300:486&#x2013;489. doi: 10.1126/science.1079469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1079469</ArticleId><ArticleId IdType="pubmed">12702875</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub J.E., Thirumalai D. Toward a molecular theory of early and late events in monomer to amyloid fibril formation. Annu. Rev. Phys. Chem. 2011;62:437&#x2013;463. doi: 10.1146/annurev-physchem-032210-103526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physchem-032210-103526</ArticleId><ArticleId IdType="pubmed">21219143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray S., Singh N., et al. Maji S.K. &#x3b1;-Synuclein aggregation nucleates through liquid&#x2013;liquid phase separation. Nat. Chem. 2020;12:705&#x2013;716. doi: 10.1038/s41557-020-0465-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41557-020-0465-9</ArticleId><ArticleId IdType="pubmed">32514159</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti S., Gladfelter A., Mittag T. Considerations and challenges in studying liquid-liquid phase separation and biomolecular condensates. Cell. 2019;176:419&#x2013;434. doi: 10.1016/j.cell.2018.12.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.12.035</ArticleId><ArticleId IdType="pmc">PMC6445271</ArticleId><ArticleId IdType="pubmed">30682370</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyko S., Surewicz K., Surewicz W.K. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2020;117:31882&#x2013;31890. doi: 10.1073/pnas.2012460117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2012460117</ArticleId><ArticleId IdType="pmc">PMC7749306</ArticleId><ArticleId IdType="pubmed">33262278</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., et al. Alberti S. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Sun F., et al. Luo S.Z. Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J.&#xa0;Mol. Biol. 2020;432:467&#x2013;483. doi: 10.1016/j.jmb.2019.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.11.017</ArticleId><ArticleId IdType="pubmed">31805282</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., et al. Fawzi N.L. ALS mutations disrupt phase separation mediated by alpha-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., et al. Taylor J. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Pak C.W., Kosno M., et al. Rosen M. Sequence determinants of intracellular phase separation by complex coacervation of a disordered protein. Mol. Cell. 2016;63:72&#x2013;85. doi: 10.1016/j.molcel.2016.05.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.05.042</ArticleId><ArticleId IdType="pmc">PMC4973464</ArticleId><ArticleId IdType="pubmed">27392146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Martinez F.J., Yeo G.W. Genetic mutations in RNA-binding proteins and their roles in ALS. Hum. Genet. 2017;136:1193&#x2013;1214. doi: 10.1007/s00439-017-1830-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00439-017-1830-7</ArticleId><ArticleId IdType="pmc">PMC5602095</ArticleId><ArticleId IdType="pubmed">28762175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I., Kato M., et al. McKnight S. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell. 2013;155:1049&#x2013;1060. doi: 10.1016/j.cell.2013.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.10.033</ArticleId><ArticleId IdType="pmc">PMC4010232</ArticleId><ArticleId IdType="pubmed">24267890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapeli K., Pratt G.A., et al. Yeo G.W. Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses. Nat. Commun. 2016;7:12143. doi: 10.1038/ncomms12143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12143</ArticleId><ArticleId IdType="pmc">PMC4935974</ArticleId><ArticleId IdType="pubmed">27378374</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Bentmann E., et al. Mackenzie I.R.A. FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain. 2011;134:2595&#x2013;2609. doi: 10.1093/brain/awr201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr201</ArticleId><ArticleId IdType="pmc">PMC3170539</ArticleId><ArticleId IdType="pubmed">21856723</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., et al. Gitler A.D. Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2012;21:2899&#x2013;2911. doi: 10.1093/hmg/dds116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds116</ArticleId><ArticleId IdType="pmc">PMC3373238</ArticleId><ArticleId IdType="pubmed">22454397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Gal J., et al. Zhu H. Self-assembled FUS binds active chromatin and regulates gene transcription. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2014;111:17809&#x2013;17814. doi: 10.1073/pnas.1414004111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1414004111</ArticleId><ArticleId IdType="pmc">PMC4273402</ArticleId><ArticleId IdType="pubmed">25453086</ArticleId></ArticleIdList></Reference><Reference><Citation>March Z.M., King O.D., Shorter J. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease. Brain Res. 2016;1647:9&#x2013;18. doi: 10.1016/j.brainres.2016.02.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.02.037</ArticleId><ArticleId IdType="pmc">PMC5003744</ArticleId><ArticleId IdType="pubmed">26996412</ArticleId></ArticleIdList></Reference><Reference><Citation>Toombs J.A., McCarty B.R., Ross E.D. Compositional determinants of prion formation in yeast. Mol. Cell Biol. 2010;30:319&#x2013;332. doi: 10.1128/mcb.01140-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.01140-09</ArticleId><ArticleId IdType="pmc">PMC2798286</ArticleId><ArticleId IdType="pubmed">19884345</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash P.E., Zhang Y.J., et al. Link C.D. Neurotoxic effects of TDP-43 overexpression in C. elegans. Hum. Mol. Genet. 2010;19:3206&#x2013;3218. doi: 10.1093/hmg/ddq230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq230</ArticleId><ArticleId IdType="pmc">PMC2908471</ArticleId><ArticleId IdType="pubmed">20530643</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Diaz Z., et al. Gitler A.D. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS. PLoS Biol. 2011;9:e1000614. doi: 10.1371/journal.pbio.1000614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.1000614</ArticleId><ArticleId IdType="pmc">PMC3082519</ArticleId><ArticleId IdType="pubmed">21541367</ArticleId></ArticleIdList></Reference><Reference><Citation>Carballo-Pacheco M., Strodel B. Advances in the simulation of protein aggregation at the atomistic scale. J.&#xa0;Phys. Chem. B. 2016;120:2991&#x2013;2999. doi: 10.1021/acs.jpcb.6b00059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.6b00059</ArticleId><ArticleId IdType="pubmed">26965454</ArticleId></ArticleIdList></Reference><Reference><Citation>Dror R.O., Dirks R.M., et al. Shaw D.E. Biomolecular simulation: a computational microscope for molecular biology. Annu. Rev. Biophys. 2012;41:429&#x2013;452. doi: 10.1146/annurev-biophys-042910-155245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-biophys-042910-155245</ArticleId><ArticleId IdType="pubmed">22577825</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen M.C., Gnutt D., et al. Strodel B. Effects of in&#xa0;vivo conditions on amyloid aggregation. Chem. Soc. Rev. 2019;48:3946&#x2013;3996. doi: 10.1039/c8cs00034d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c8cs00034d</ArticleId><ArticleId IdType="pubmed">31192324</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler R.L., Shirvanyants D., et al. Dokholyan N.V. Computational approaches to understanding protein aggregation in neurodegeneration. J.&#xa0;Mol. Cell Biol. 2014;6:104&#x2013;115. doi: 10.1093/jmcb/mju007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mju007</ArticleId><ArticleId IdType="pmc">PMC3995224</ArticleId><ArticleId IdType="pubmed">24620031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei G., Mousseau N., Derreumaux P. Computational simulations of the early steps of protein aggregation. Prion. 2007;1:3&#x2013;8. doi: 10.4161/pri.1.1.3969.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.1.1.3969</ArticleId><ArticleId IdType="pmc">PMC2633700</ArticleId><ArticleId IdType="pubmed">19164927</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen J., Scoles D.R., Facelli J.C. Molecular dynamics analysis of the aggregation propensity of polyglutamine segments. PLoS One. 2017;12:e0178333. doi: 10.1371/journal.pone.0178333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178333</ArticleId><ArticleId IdType="pmc">PMC5444867</ArticleId><ArticleId IdType="pubmed">28542401</ArticleId></ArticleIdList></Reference><Reference><Citation>Galm L., Amrhein S., Hubbuch J. Predictive approach for protein aggregation: correlation of protein surface characteristics and conformational flexibility to protein aggregation propensity. Biotechnol. Bioeng. 2017;114:1170&#x2013;1183. doi: 10.1002/bit.25949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bit.25949</ArticleId><ArticleId IdType="pubmed">26853436</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassmann G., Miotto M., et al. Milanetti E. A computational approach to investigate TDP-43 RNA-recognition motif 2 C-terminal fragments aggregation in amyotrophic lateral sclerosis. Biomolecules. 2021;11:1905. doi: 10.3390/biom11121905.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11121905</ArticleId><ArticleId IdType="pmc">PMC8699346</ArticleId><ArticleId IdType="pubmed">34944548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Y.K., Tajoddin N.N., et al. Konermann L. Mechanism of thermal protein aggregation: experiments and molecular dynamics simulations on the high-temperature behavior of myoglobin. J.&#xa0;Phys. Chem. B. 2021;125:13099&#x2013;13110. doi: 10.1021/acs.jpcb.1c07210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.1c07210</ArticleId><ArticleId IdType="pubmed">34808050</ArticleId></ArticleIdList></Reference><Reference><Citation>King O.D., Gitler A.D., Shorter J. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease. Brain Res. 2012;1462:61&#x2013;80. doi: 10.1016/j.brainres.2012.01.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.01.016</ArticleId><ArticleId IdType="pmc">PMC3372647</ArticleId><ArticleId IdType="pubmed">22445064</ArticleId></ArticleIdList></Reference><Reference><Citation>Couthouis J., Hart M.P., et al. Gitler A.D. A yeast functional screen predicts new candidate ALS disease genes. Proc. Natl. Acad. Sci. U&#xa0;S&#xa0;A. 2011;108:20881&#x2013;20890. doi: 10.1073/pnas.1109434108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1109434108</ArticleId><ArticleId IdType="pmc">PMC3248518</ArticleId><ArticleId IdType="pubmed">22065782</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi V., Xu Q., et al. Dunbrack R.L., Jr. Assessment of template-based modeling of protein structure in CASP11. Proteins. 2016;84:200&#x2013;220. doi: 10.1002/prot.25049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25049</ArticleId><ArticleId IdType="pmc">PMC5030193</ArticleId><ArticleId IdType="pubmed">27081927</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryshtafovych A., Monastyrskyy B., et al. Tramontano A. Evaluation of the template-based modeling in CASP12. Proteins. 2018;86:321&#x2013;334. doi: 10.1002/prot.25425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/prot.25425</ArticleId><ArticleId IdType="pmc">PMC5877821</ArticleId><ArticleId IdType="pubmed">29159950</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker D., Sali A. Protein structure prediction and structural genomics. Science. 2001;294:93&#x2013;96. doi: 10.1126/science.1065659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1065659</ArticleId><ArticleId IdType="pubmed">11588250</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison A.F., Shorter J. RNA-binding proteins with prion-like domains in health and disease. Biochem.&#xa0;J. 2017;474:1417&#x2013;1438. doi: 10.1042/bcj20160499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bcj20160499</ArticleId><ArticleId IdType="pmc">PMC5639257</ArticleId><ArticleId IdType="pubmed">28389532</ArticleId></ArticleIdList></Reference><Reference><Citation>Abraham M.J., Murtola T., et al. Lindahl E. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19&#x2013;25. doi: 10.1016/j.softx.2015.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.softx.2015.06.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey W., Dalke A., Schulten K. VMD: visual molecular dynamics. J.&#xa0;Mol. Graph. 1996;14:33&#x2013;38. doi: 10.1016/0263-7855(96)00018-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0263-7855(96)00018-5</ArticleId><ArticleId IdType="pubmed">8744570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Cheng X., et al. Im W. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM simulations using the CHARMM36 additive force field. J.&#xa0;Chem. Theor. Comput. 2015;12:405&#x2013;413. doi: 10.1021/acs.jctc.5b00935.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jctc.5b00935</ArticleId><ArticleId IdType="pmc">PMC4712441</ArticleId><ArticleId IdType="pubmed">26631602</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo S., Kim T., et al. Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J.&#xa0;Comput. Chem. 2008;29:1859&#x2013;1865. doi: 10.1002/jcc.20945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20945</ArticleId><ArticleId IdType="pubmed">18351591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekker H., van den Berg J.P., Wassenaar T.A. A method to obtain a near-minimal-volume molecular simulation of a macromolecule, using periodic boundary conditions and rotational constraints. J.&#xa0;Comput. Chem. 2004;25:1037&#x2013;1046. doi: 10.1002/jcc.20050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcc.20050</ArticleId><ArticleId IdType="pubmed">15067679</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess B. P-LINCS:&#x2009; A parallel linear constraint solver for molecular simulation. J.&#xa0;Chem. Theor. Comput. 2008;4:116&#x2013;122. doi: 10.1021/ct700200b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ct700200b</ArticleId><ArticleId IdType="pubmed">26619985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawata M., Nagashima U. Particle mesh Ewald method for three-dimensional systems with two-dimensional periodicity. Chem. Phys. Lett. 2001;340:165&#x2013;172. doi: 10.1016/s0009-2614(01)00393-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0009-2614(01)00393-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussi G., Donadio D., Parrinello M. Canonical sampling through velocity rescaling. J.&#xa0;Chem. Phys. 2007;126 doi: 10.1063/1.2408420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.2408420</ArticleId><ArticleId IdType="pubmed">17212484</ArticleId></ArticleIdList></Reference><Reference><Citation>Carretero-Gonz&#xe1;lez R., Kevrekidis P.G., et al. Frantzeskakis D.J. A Parrinello-Rahman approach to vortex lattices. Phys. Lett. 2005;341:128&#x2013;134. doi: 10.1016/j.physleta.2005.04.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.physleta.2005.04.046</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini A., Chauhan V.S. Delineation of the core aggregation sequences of TDP-43 C-terminal fragment. Chembiochem. 2011;12:2495&#x2013;2501. doi: 10.1002/cbic.201100427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.201100427</ArticleId><ArticleId IdType="pubmed">21905193</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak W.M., Haider R., et al. Surewicz W.K. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain. J.&#xa0;Biol. Chem. 2019;294:6306&#x2013;6317. doi: 10.1074/jbc.ra118.007222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.ra118.007222</ArticleId><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K., Liu J.Q., et al. Liang Y. Phase separation and cytotoxicity of tau are modulated by protein disulfide isomerase and S-nitrosylation of this molecular chaperone. J.&#xa0;Mol. Biol. 2020;432:2141&#x2013;2163. doi: 10.1016/j.jmb.2020.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.02.013</ArticleId><ArticleId IdType="pubmed">32087196</ArticleId></ArticleIdList></Reference><Reference><Citation>Monahan Z., Ryan V.H., et al. Fawzi N.L. Phosphorylation of&#xa0;the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity. EMBO&#xa0;J. 2017;36:2951&#x2013;2967. doi: 10.15252/embj.201696394.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201696394</ArticleId><ArticleId IdType="pmc">PMC5641905</ArticleId><ArticleId IdType="pubmed">28790177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Chen H., et al. Lai L. Molecular dynamics simulations on the oligomer-formation process of the GNNQQNY peptide from yeast prion protein Sup35. Biophys.&#xa0;J. 2007;93:1484&#x2013;1492. doi: 10.1529/biophysj.106.100537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1529/biophysj.106.100537</ArticleId><ArticleId IdType="pmc">PMC1948036</ArticleId><ArticleId IdType="pubmed">17483185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Agnihotri M.V., et al. Singer S.J. A theoretical study of polymorphism in VQIVYK fibrils. Biophys.&#xa0;J. 2021;120:1396&#x2013;1416. doi: 10.1016/j.bpj.2021.01.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2021.01.032</ArticleId><ArticleId IdType="pmc">PMC8105716</ArticleId><ArticleId IdType="pubmed">33571490</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvarenga L.M., Machado de Avila R.A., et al. Ch&#xe1;vez-Ol&#xf3;rtegui C. Molecular characterization of a neutralizing murine monoclonal antibody against Tityus serrulatus scorpion venom. Toxicon. 2005;46:664&#x2013;671. doi: 10.1016/j.toxicon.2005.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.toxicon.2005.07.014</ArticleId><ArticleId IdType="pubmed">16168449</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>